Business Context and Reporting Period
This Form 8-K Current Report for OneMedNet Corporation (ONMD) covers events occurring between June 14, 2024, and June 18, 2024. The filing details the termination of a prior financing agreement and the execution of a new Standby Equity Purchase Agreement (SEPA) and convertible promissory note with Yorkville Advisors Global, LP.
Key Financial Metrics and Agreements
- SEPA Capacity: The Company has the option to sell up to $25 million of Common Stock to Yorkville over a 24-month period.
- SEPA Pricing: Shares are purchased at 97% of the Market Price, subject to a minimum acceptable price set by the Company.
- Issuance Limits: Yorkville cannot beneficially own more than 4.99% of voting power, and total shares issued under the SEPA cannot exceed 19.99% of outstanding shares (the "Exchange Cap") without shareholder approval.
- Convertible Promissory Note: A $1.5 million principal amount was advanced on June 18, 2024, due June 18, 2025.
- Note Interest: 0% annual rate, increasing to 18% upon an event of default.
- Note Conversion: Convertible at the lower of a Fixed Price ($1.3408) or 90% of the lowest daily VWAP over seven trading days, subject to a Floor Price of $0.28.
- Fees: A $25,000 structuring fee was paid, and a $500,000 commitment fee is payable in shares in two tranches.
- Termination Costs: The Company agreed to reimburse legal fees and issue a warrant for 50,000 shares at $1.20 per share to terminate a prior agreement with Helena Global.
Material Changes Versus Prior Period
The filing reports a significant shift in capital structure strategy. The Company terminated a definitive securities purchase agreement with Helena Global Investment Opportunities 1 Ltd. that provided for up to $4.54 million in funding. This was immediately replaced by the new SEPA and $1.5 million bridge note with Yorkville. The filing does not provide comparative revenue, profit, or cash flow metrics as this is a current report on specific events rather than a periodic financial statement.
Guidance, Outlook, Risks, and Contingencies
- Registration Rights: The Company must file a resale registration statement by August 30, 2024, and have it declared effective within 30 days to utilize the SEPA.
- Amortization Risk: The Promissory Note may become amortizable for cash if the daily VWAP falls below the Floor Price ($0.28) for five trading days within a seven-day period, or if the Company issues over 95% of the Exchange Cap.
- Default Risk: Interest on the note accelerates to 18% and the note may be accelerated upon specified events of default.
- Shareholder Approval: Issuances exceeding the 19.99% Exchange Cap require shareholder approval.
Investor Verification Checklist
- Verify the effectiveness of the resale registration statement by the August 30, 2024 deadline.
- Monitor the daily VWAP relative to the $0.28 Floor Price to assess potential cash amortization triggers on the $1.5 million note.
- Review the impact of the 19.99% Exchange Cap on future fundraising flexibility under the SEPA.
- Confirm the dilution impact of the $500,000 commitment fee payable in shares and the 50,000 warrant issued to Helena Global.
- Check for any subsequent filings regarding the repayment of the $1.5 million Promissory Note or conversion events.